GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan

Bulletin Express08-06

GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:

• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.

• Considering the declaration of an interim dividend, if any.

The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.

Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124539406?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 06:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124539406","market":"hk","top_or_hot":-1,"title":"GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.</p>\n<p>Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 06:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.</p>\n<p>Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1124539406","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124539406","pubTimestamp":1785967687,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes: • Reviewing and approving the consolidated interim results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics 定于 2026 年 8 月 21 日召开董事会会议，批准 2026 年上半年中期业绩和股息计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:\n• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.\n• Considering the declaration of an interim dividend, if any.\nThe notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.\nCurrent board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124539406","isCrawlerRequest":true}